India’s PM Ponders Ways To Encourage Innovative Drug Work
This article was originally published in PharmAsia News
Executive Summary
India's prime minister is considering a proposal for the government to support the kind of medical research the pharmaceutical industry finds too expensive and risky to undertake. The proposal is part of a package of regulatory reforms being studied to encourage drug discovery, support clinical trials and provide approvals of products at different stages of development. The package is part of a $2 billion drug research funding plan that emerged from a series of meetings with drug makers to identify roadblocks that stand in the way of innovative drugs. (Click here for more
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.